ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 170 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,358,322 | -30.6% | 428,493 | +8.3% | 0.00% | -25.0% |
| Q2 2023 | $1,956,557 | +8.5% | 395,723 | +8.4% | 0.00% | 0.0% |
| Q1 2023 | $1,802,971 | -14.9% | 364,974 | +8.4% | 0.00% | -33.3% |
| Q4 2022 | $2,117,648 | -49.1% | 336,669 | -12.6% | 0.01% | -45.5% |
| Q3 2022 | $4,161,000 | +11.9% | 385,261 | +18.1% | 0.01% | +22.2% |
| Q2 2022 | $3,719,000 | -4.4% | 326,196 | -23.7% | 0.01% | +125.0% |
| Q1 2022 | $3,892,000 | +3.3% | 427,262 | +69.2% | 0.00% | -50.0% |
| Q4 2021 | $3,767,000 | -32.2% | 252,460 | +16.8% | 0.01% | -42.9% |
| Q3 2021 | $5,553,000 | +22.7% | 216,082 | +24.6% | 0.01% | +7.7% |
| Q2 2021 | $4,524,000 | -17.9% | 173,454 | +11.2% | 0.01% | -31.6% |
| Q1 2021 | $5,509,000 | +154.0% | 156,053 | +81.6% | 0.02% | +137.5% |
| Q4 2020 | $2,169,000 | +11.9% | 85,926 | +67.1% | 0.01% | -20.0% |
| Q3 2020 | $1,939,000 | +28.3% | 51,409 | +45.7% | 0.01% | +11.1% |
| Q2 2020 | $1,511,000 | – | 35,288 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $46,213,000 | 13.24% |
| Wildcat Capital Management, LLC | 1,716,370 | $44,111,000 | 5.71% |
| TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $481,009,000 | 4.77% |
| Copernicus Capital Management, LLC | 15,000 | $386,000 | 4.67% |
| Coastal Bridge Advisors, LLC | 301,240 | $7,742,000 | 1.79% |
| Lombard Odier Asset Management (Switzerland) SA | 914,416 | $23,500,000 | 1.46% |
| Casdin Capital, LLC | 2,100,000 | $53,970,000 | 1.34% |
| Pier Capital, LLC | 450,182 | $11,570,000 | 1.20% |
| Ghost Tree Capital, LLC | 150,000 | $3,855,000 | 1.13% |
| Sessa Capital IM, L.P. | 750,000 | $19,275,000 | 0.95% |